ChartMill assigns a Buy % Consensus number of 88% to ORKA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2026-01-12 | BTIG | Maintains | Buy -> Buy |
| 2026-01-07 | UBS | Initiate | Buy |
| 2025-12-18 | Piper Sandler | Initiate | Overweight |
| 2025-11-13 | BTIG | Maintains | Buy -> Buy |
| 2025-11-13 | Jefferies | Initiate | Buy |
| 2025-10-27 | Guggenheim | Initiate | Buy |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-13 | Barclays | Initiate | Overweight |
| 2025-09-29 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-17 | Clear Street | Maintains | Buy -> Buy |
| 2025-09-17 | BTIG | Maintains | Buy -> Buy |
| 2025-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | Wolfe Research | Initiate | Outperform |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Stifel | Initiate | Buy |
| 2024-10-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-09-17 | Leerink Swann | Initiate | Outperform |
| 2024-09-17 | Leerink Partners | Initiate | Outperform |
| 2024-09-16 | LifeSci Capital | Initiate | Outperform |
| 2024-09-16 | TD Cowen | Initiate | Buy |
| 2024-09-13 | Jefferies | Initiate | Buy |
| 2024-09-04 | Wedbush | Initiate | Outperform |
19 analysts have analysed ORKA and the average price target is 56.44 USD. This implies a price increase of 60.52% is expected in the next year compared to the current price of 35.16.
The consensus rating for ORUKA THERAPEUTICS INC (ORKA) is 88.4211 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ORUKA THERAPEUTICS INC (ORKA) is 19.